| RECOMMENDATION 3 |
| We recommend that patients who are suspected to have HAE and have normal C1–INH levels and function are assessed for known mutations underlying HAE-nC1-INH. |
| 91% agreement, evidence level D |
| RECOMMENDATION 3 |
| We recommend that patients who are suspected to have HAE and have normal C1–INH levels and function are assessed for known mutations underlying HAE-nC1-INH. |
| 91% agreement, evidence level D |